Liposomes as Adjuvants for Vaccines,

Abstract

Numerous reviews of liposomes as carriers of antigens and adjuvants have been published since 1990. Liposomes have the advantage of being biodegradable vehicles that mimic the lipid structure of natural lipid bilayer membranes. Because of this, insoluble membrane antigens can often be reconstituted in a form that exposes purified antigenic epitopes, such as purified viral antigens, in conformations that are presumed to be similar to those found in the original organism. Liposomes are also avidly ingested by phagocytes, cells then serving as antigen-presenting cells. In addition to these natural attributes, liposomes also have the convenient characteristic of encapsulating soluble antigens and then serving as permeability barriers for slow release of the antigens. Besides antigens, additional adjuvants, such as lipid A (the lipid moiety of gram-negative bacterial lipopolysaccharide) or lipophilic muramyl dipeptide (MDP) derivatives and analogs, can be incorporated either into the lipid bilayer or encapsulated (if soluble) in the aqueous regions.

Open PDF

Document Details

Document Type
Technical Report
Publication Date
Jan 01, 1997
Accession Number
ADA331198

Entities

People

  • Carl R. Alving

Organizations

  • Walter Reed Army Institute of Research

Tags

DTIC Thesaurus Topics

  • Abstracts
  • Acquired Immune Deficiency Syndrome
  • Antigens
  • Biological Factors
  • Cells
  • Immunization
  • Lymphocytes
  • Medical Personnel
  • Membrane Lipids
  • New York
  • Rodents
  • Synthetic Membranes
  • T Lymphocytes
  • United States
  • Vaccines
  • Viruses

Fields of Study

  • Biology

Readers

  • Immunology
  • Underwater engineering and Marine Technology.

Technology Areas

  • Biotechnology
  • Biotechnology - Cancer Biotech